Results 61 to 70 of about 7,267 (158)
Incidence of CHIKV infections among individuals with negative baseline CHIKV PRNT in different age groups.a
, 2015 aBased on 614 subjects with both enrollment and 12-month blood collections who had negative baseline CHIKV PRNT titer.bCHIKV PRNT titer at enrollment using 80% plaque reduction.CHIKV = chikungunya virus; n = number; CI = confidence interval; PRNT ...Chonticha Klungthong (287990), Laura L. Hermann (638244), Jens W. Levy (736011), Louis R. Macareo (622641), Butsaya Thaisomboonsuk (287993), Henrik Salje (589157), Stefan Fernandez (146590), Vito G. Roque Jr. (706827), John Mark Velasco (736012), Maria Theresa Alera (736007), Anon Srikiatkhachorn (110184), Catherine B. Lago (736008), Daisy Villa (736010), In-Kyu Yoon (150936), Ananda Nisalak (20034), Ilya A. Tac-An (736009) +15 morecore +1 more source17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil
Emerging Infectious Diseases, 2019 We evaluated the duration of neutralizing antibodies and the status of 17DD vaccine–specific T- and B-cell memory following primary and revaccination regimens for yellow fever (YF) in Brazil.Olindo Assis Martins-Filho, Vanessa Peruhype-Magalhāes, Jordana Grazziela Coelho-dos-Reis, Lis Ribeiro Antonelli, Christiane Costa-Pereira, Elaine Speziali, Laise Rodrigues Reis, Jandira Aparecida Lemos, José Geraldo Leite Ribeiro, Luiz Antônio Bastos Camacho, Maria de Lourdes de Sousa Maia, Sheila Maria Barbosa de Lima, Marisol Simões, Reinaldo de Menezes Martins, Akira Homma, Luiz Cosme Cota Malaquias, Pedro Luiz Tauil, Pedro Fernando Costa Vasconcelos, Alessandro Pecego Martins Romano, Carla Magda Domingues, Andréa Teixeira-Carvalho, Ana Carolina Campi-Azevedo +21 moredoaj +1 more sourceMulticentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects
Scientific ReportsDiagnosis of SARS-CoV-2 virus is mainly based on direct detection. Determination of specific antibodies has been used mostly for epidemiological reasons.Miroslav Fajfr, Petr Pajer, Daniel Ruzek, Radek Sleha, Sylva Janovska, Milos Bohonek, Hana Kabickova, Pavla Kubicková, Michal Stefanik, Petra Strakova, Pavel Bostik +10 moredoaj +1 more sourceVaccinia-specific PRNT GMTs by Week (IAS, N = 119).
, 2016 Administrations at week 0 (Group MM: first MVA vaccination; Group PM: Placebo) and at week 4 (Group MM: second MVA vaccination; Group PM: first MVA vaccination). No samples were taken between week 8 and 32, therefore the graph was cut.Richard Nichols (604329), Eva Wagner (3165195), Alfred von Krempelhuber (724926), Jack T. Stapleton (93816), Philip Young (803781), Christine M. Hay (145141), Paul Chaplin (366377), Thomas P. Meyer (3165189), Richard N. Greenberg (3165183), Josef Weigl (3165186), Darja Schmidt (803780), Garth Virgin (724929), Thomas C. Marbury (3165180), Nathaly Arndtz-Wiedemann (724925), Eva Kreitmeir (3165198), Siegfried Röesch (3165192) +15 morecore +1 more sourcePerformance of the dengue IgG rapid test and dengue IgG ELISA for serostatus determination using the plaque reduction neutralization test (PRNT) as the reference assay.
, 2021 Performance of the dengue IgG rapid test and dengue IgG ELISA for serostatus determination using the plaque reduction neutralization test (PRNT) as the reference assay.Nattachai Srisawat (832518), Chatchai Chulapornsiri (11420414), Terapong Tantawichien (305291), Umaporn Limothai (9268591), Taweewun Hunsawong (798675), Usa Thisyakorn (268282), Prapapun Ong-ajchaowlerd (11420405), Anongrat Tiawilai (11420417), Butsaya Thaisomboonsuk (287993), Stefan Fernandez (146590), Supachoke Trongkamolchai (11420408), Mananya Wanpaisitkul (11420411), Thawat Tiawilai (11420420), Sasipha Tachaboon (9629163), Janejira Dinhuzen (9629157) +14 morecore +1 more sourceNeutralization efficacy of high-potency human antibodies against SARS-CoV-2 Delta variant assessed by the plaque reduction neutralization test (PRNT).
, 2023 Neutralization efficacy of high-potency human antibodies against SARS-CoV-2 Delta variant assessed by the plaque reduction neutralization test (PRNT).Nattachai Srisawat (832518), Thittaya Audomsun (15411683), Terapong Tantawichien (305291), Tossapon Wongtangprasert (14106530), Tanapati Phakham (11412074), Watchadaporn Chaisuriyong (11914502), Pijitra Saelao (15411689), Dorota Focht (9461252), Martin Welin (161726), Usa Thisyakorn (268282), Taweewun Hunsawong (798675), Chatikorn Boonkrai (11412077), Matthew Reed (3643819), Aijaz Ahmad Malik (10358074), Stefan Fernandez (146590), Trairak Pisitkun (390908), Thomas S. Cotrone (15411680), Raymond Kimbung (9461249), Chadaporn Attakitbancha (15411686) +18 morecore +1 more sourceGMT for ELISA and PRNT at all post-baseline visits (FAS, N = 632).
, 2015 N = number of subjects in the specified group.GMT for ELISA and PRNT at all post-baseline visits (FAS, N = 632).Siegfried Roesch (803778), Richard Nichols (604329), Dorothea von Bredow (803777), Thomas Peter Meyer (803779), Alfred von Krempelhuber (724926), Philip Young (803781), Dinh V. Dinh (803774), Serena Mraz (803775), Paul Chaplin (366377), Darja Schmidt (803780), Garth Virgin (724929), Nathaly Arndtz-Wiedemann (724925), Richard N Greenberg (803772), Yadira Hurley (803773), Javier Gomez Vera (803776) +14 morecore +1 more source